Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,300 papers from all fields of science
Search
Sign In
Create Free Account
ex vivo-expanded HER2-specific T cells
Known as:
HER2 Specific T-Cells
T cells specific for the human epidermal growth factor receptor 2 (HER2) with potential immunopotentiating activity. T cells directed against HER2…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Antigen Sensitization
Cytotoxic T-Lymphocytes
T-Cell Activation
immunopotentiation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Cytotoxicity of targeted HER2-specific phototoxins based on flavoprotein miniSOG is determined by the rate of their internalization
O. Shilova
,
G. Proshkina
,
A. Ryabova
,
S. M. Deyev
,
R. Petrov
Doklady Biochemistry and Biophysics
2017
Corpus ID: 19640185
The concept of targeted therapy implies the development of bifunctional agents complementing the therapeutic module with a…
Expand
2016
2016
HER2-specific DARPin-Liposomes: fabrication and characterization
E. Guryev
,
N. Antonova
,
+6 authors
A. Zvyagin
2016
Corpus ID: 105208003
2013
2013
HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy.
Jinho Park
,
Seho Park
,
+8 authors
S. Jon
Journal of materials chemistry. B
2013
Corpus ID: 135986952
Here, we report a nanotheranostic system that enables simultaneous imaging and therapy of HER2-overexpressing tumors. We first…
Expand
2010
2010
Abstract P3-14-23: Affitoxin — A Potent Therapeutic Agent for Treatment of HER2- Overexpressing Tumors
Rafal Zieliński
,
I. Lyakhov
,
Moinuddin Hassan
,
Monika Kuban
,
K. Shafer-Weaver
,
J. Capala
2010
Corpus ID: 72349761
Introduction: Cancers overexpressing HER2 gene are usually described as more aggressive and are associated with poor prognosis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE